Polar Asset Management Partners’s Verona Pharma VRNA Stock Holding History

Polar Asset Management Partners’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-970,000	Closed	-$104M	–	840
2025 Q3	$104M	Buy	970,000 +958,400	+8,262%	+$100M	1.16%	9
2025 Q2	$1.1M	Sell	11,600 -107,227	-90%	-$7.94M	0.02%	360
2025 Q1	$7.54M	Buy	+118,827	New	+$7.11M	0.17%	145
2024 Q2	–	Sell	-96,500	Closed	-$1.55M	–	838
2024 Q1	$1.55M	Hold	96,500	–	–	0.03%	392
2023 Q4	$1.92M	Hold	96,500	–	–	0.03%	375
2023 Q3	$1.57M	Hold	96,500	–	–	0.03%	417
2023 Q2	$2.04M	Hold	96,500	–	–	0.04%	456
2023 Q1	$1.94M	Buy	+96,500	New	+$2.08M	0.03%	514

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Polar Asset Management Partners's VRNA Position: Q4 2025 in Review

Polar Asset Management Partners sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 970,000 shares — an estimated $104M sold.

Polar Asset Management Partners first reported a position in VRNA in Q1 2023 and held it in 8 quarters. The position peaked at $104M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Polar Asset Management Partners reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Polar Asset Management Partners sold 970,000 Verona Pharma shares in Q4 2025, an estimated $104M.
Polar Asset Management Partners first reported a position in Verona Pharma in Q1 2023 and held it in 8 quarters.
Polar Asset Management Partners's Verona Pharma position peaked at $104M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Polar Asset Management Partners's 13F filing for Q4 2025, filed 17 Feb 2026.